Security key
35104E100
4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (FDMT)
CUSIP: 35104E100
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 26,027,061
- Total 13F value
- $181,670,139
- Share change
- -74,800
- SEC-reported price per share
- $6.98
- Number of holders
- 86
- Value change
- -$2,172,042
- Number of buys
- 50
- Number of sells
- 32
- Shares outstanding
- 51,571,939
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2022
Institutions
86
Top holders
10
FDMT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
4D Molecular Therapeutics, Inc. SEC filings
4D Molecular Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 35104E100
Recent filing periods:
Ownership snapshot
Top reported holders of FDMT - 4D Molecular Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
VIKING GLOBAL INVESTORS LP
Disclosed value leader
VIKING GLOBAL INVESTORS LP
Comparable rows
15/15
Latest evidence
31 Mar 2022
13F
Lead comparable stake: 7.6%
Showing 1-6 of 15 holder rows.
Quick read
VIKING GLOBAL INVESTORS LP leads the comparable SEC ownership view at 7.6%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens VIKING GLOBAL INVESTORS LP's linked filing trail.
Comparable ownership
Top 5
VIKING GLOBAL INVESTORS LP
7.6%
BVF INC/IL
5.2%
Deep Track Capital, LP
4.7%
BlackRock Finance, Inc.
4.1%
Aquilo Capital Management, LLC
3.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP |
13F
Company
|
7.6%
|
$59,541,000
3,937,914 shares
|
— | 31 Mar 2022 |
| BVF INC/IL |
13F
Company
|
5.2%
|
$40,288,000
2,664,521 shares
|
— | 31 Mar 2022 |
| Deep Track Capital, LP |
13F
Company
|
4.7%
|
$37,017,000
2,448,200 shares
|
— | 31 Mar 2022 |
| BlackRock Finance, Inc. |
13F
Company
|
4.1%
|
$32,208,000
2,130,226 shares
|
— | 31 Mar 2022 |
| Aquilo Capital Management, LLC |
13F
Company
|
3.4%
|
$26,543,000
1,755,506 shares
|
— | 31 Mar 2022 |
| Janus Henderson Group Ltd. |
13F
Company
|
3.2%
|
$25,175,000
1,665,411 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
86
Shares
26,027,061
Rows available
86
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
76
Q2 2022 holders
86
Holder diff
10
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend